The Vanguard Group Discloses Stake in Spire Healthcare

The Vanguard Group, Inc. has submitted a Form 8.3 as part of the UK Takeover Code, revealing a 3.57% interest in Spire Healthcare Group plc. The disclosure, dated 14 November 2025, indicates that Vanguard holds 14,383,099 ordinary 1p shares of Spire. There are no additional cash or stock-settled derivatives reported.

On 13 November 2025, Vanguard executed a sale of 2,502 ordinary shares at 2.25 GBP each. No derivative transactions or agreements affecting voting rights were disclosed, aligning with Rule 8.3 requirements under the UK Takeover Code. No Supplemental Form 8 indicating open positions was attached to the disclosure.

For queries, Vanguard lists Shawn Acker as the contact person, reachable via phone at 001-610-669-6713. The disclosure underscores Vanguard's investment activities in the UK healthcare sector amid evolving market conditions.